156 related articles for article (PubMed ID: 30645608)
1. Plasma growth differentiation factor-15 is an independent marker for aggressive disease in endometrial cancer.
Engerud H; Hope K; Berg HF; Fasmer KE; Tangen IL; Haldorsen IS; Trovik J; Krakstad C
PLoS One; 2019; 14(1):e0210585. PubMed ID: 30645608
[TBL] [Abstract][Full Text] [Related]
2. Elevated plasma growth differentiation factor-15 correlates with lymph node metastases and poor survival in endometrial cancer.
Staff AC; Trovik J; Eriksson AG; Wik E; Wollert KC; Kempf T; Salvesen HB
Clin Cancer Res; 2011 Jul; 17(14):4825-33. PubMed ID: 21616994
[TBL] [Abstract][Full Text] [Related]
3. Growth differentiation factor-15 as biomarker in uterine sarcomas.
Trovik J; Salvesen HB; Cuppens T; Amant F; Staff AC
Int J Gynecol Cancer; 2014 Feb; 24(2):252-9. PubMed ID: 24401984
[TBL] [Abstract][Full Text] [Related]
4. Expression of L1CAM in curettage or high L1CAM level in preoperative blood samples predicts lymph node metastases and poor outcome in endometrial cancer patients.
Tangen IL; Kopperud RK; Visser NC; Staff AC; Tingulstad S; Marcickiewicz J; Amant F; Bjørge L; Pijnenborg JM; Salvesen HB; Werner HM; Trovik J; Krakstad C
Br J Cancer; 2017 Sep; 117(6):840-847. PubMed ID: 28751757
[TBL] [Abstract][Full Text] [Related]
5. Growth differentiation factor-15 levels and the risk of contrast induced acute kidney injury in acute myocardial infarction patients treated invasively: A propensity-score match analysis.
Sun L; Zhou X; Jiang J; Zang X; Chen X; Li H; Cao H; Wang Q
PLoS One; 2018; 13(3):e0194152. PubMed ID: 29529072
[TBL] [Abstract][Full Text] [Related]
6. Association between Plasma Levels of Growth Differentiation Factor-15 and Renal Function in the Elderly: Korean Frailty and Aging Cohort Study.
Kim JS; Kim S; Won CW; Jeong KH
Kidney Blood Press Res; 2019; 44(3):405-414. PubMed ID: 31163432
[TBL] [Abstract][Full Text] [Related]
7. [Correlation between levels of serum growth differentiation factor-15 and acute coronary syndrome].
Zheng LB; Guo YH; Yu HY; Mi L; Wang YP; Gao W
Beijing Da Xue Xue Bao Yi Xue Ban; 2011 Apr; 43(2):250-4. PubMed ID: 21503121
[TBL] [Abstract][Full Text] [Related]
8. The utility of sentinel lymph node mapping in the management of endometrial atypical hyperplasia.
Touhami O; Grégoire J; Renaud MC; Sebastianelli A; Grondin K; Plante M
Gynecol Oncol; 2018 Mar; 148(3):485-490. PubMed ID: 29290489
[TBL] [Abstract][Full Text] [Related]
9. Growth-differentiation factor 15 and risk of major bleeding in atrial fibrillation: Insights from the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) trial.
Hijazi Z; Oldgren J; Andersson U; Connolly SJ; Eikelboom JW; Ezekowitz MD; Reilly PA; Yusuf S; Siegbahn A; Wallentin L
Am Heart J; 2017 Aug; 190():94-103. PubMed ID: 28760218
[TBL] [Abstract][Full Text] [Related]
10. Preoperative plasma growth-differentiation factor-15 for prediction of acute kidney injury in patients undergoing cardiac surgery.
Heringlake M; Charitos EI; Erber K; Berggreen AE; Heinze H; Paarmann H
Crit Care; 2016 Oct; 20(1):317. PubMed ID: 27717384
[TBL] [Abstract][Full Text] [Related]
11. Value of pre-operative serum CA125 level for prediction of prognosis in patients with endometrial cancer.
Chen YL; Huang CY; Chien TY; Huang SH; Wu CJ; Ho CM
Aust N Z J Obstet Gynaecol; 2011 Oct; 51(5):397-402. PubMed ID: 21806586
[TBL] [Abstract][Full Text] [Related]
12. Levels of Growth Differentiation Factor 15 and Early Mortality Risk Stratification in Cardiogenic Shock.
Hongisto M; Kataja A; Tarvasmäki T; Holopainen A; Javanainen T; Jurkko R; Jäntti T; Kimmoun A; Levy B; Mebazaa A; Pulkki K; Sionis A; Tolppanen H; Wollert KC; Harjola VP; Lassus J;
J Card Fail; 2019 Nov; 25(11):894-901. PubMed ID: 31310811
[TBL] [Abstract][Full Text] [Related]
13. Plasma Growth Differentiation Factor-15 is a Potential Biomarker for Pediatric Pulmonary Arterial Hypertension Associated with Congenital Heart Disease.
Li G; Li Y; Tan XQ; Jia P; Zhao J; Liu D; Wang T; Liu B
Pediatr Cardiol; 2017 Dec; 38(8):1620-1626. PubMed ID: 28819713
[TBL] [Abstract][Full Text] [Related]
14. Growth differentiation factor 15: a novel risk marker adjunct to the EuroSCORE for risk stratification in cardiac surgery patients.
Heringlake M; Charitos EI; Gatz N; Käbler JH; Beilharz A; Holz D; Schön J; Paarmann H; Petersen M; Hanke T
J Am Coll Cardiol; 2013 Feb; 61(6):672-81. PubMed ID: 23391200
[TBL] [Abstract][Full Text] [Related]
15. Hormone receptor loss in endometrial carcinoma curettage predicts lymph node metastasis and poor outcome in prospective multicentre trial.
Trovik J; Wik E; Werner HM; Krakstad C; Helland H; Vandenput I; Njolstad TS; Stefansson IM; Marcickiewicz J; Tingulstad S; Staff AC; ; Amant F; Akslen LA; Salvesen HB
Eur J Cancer; 2013 Nov; 49(16):3431-41. PubMed ID: 23932335
[TBL] [Abstract][Full Text] [Related]
16. Growth Differentiation Factor 15 at 1 Month After an Acute Coronary Syndrome Is Associated With Increased Risk of Major Bleeding.
Lindholm D; Hagström E; James SK; Becker RC; Cannon CP; Himmelmann A; Katus HA; Maurer G; López-Sendón JL; Steg PG; Storey RF; Siegbahn A; Wallentin L
J Am Heart Assoc; 2017 Apr; 6(4):. PubMed ID: 28411246
[TBL] [Abstract][Full Text] [Related]
17. Pre-operative growth differentiation factor 15 as a novel biomarker of acute kidney injury after cardiac bypass surgery.
Guenancia C; Kahli A; Laurent G; Hachet O; Malapert G; Grosjean S; Girard C; Vergely C; Bouchot O
Int J Cardiol; 2015 Oct; 197():66-71. PubMed ID: 26113476
[TBL] [Abstract][Full Text] [Related]
18. Association between growth differentiation factor-15 and chronic heart failure in coronary atherosclerosis patients.
Zhu ZD; Sun T
Genet Mol Res; 2015 Mar; 14(1):2225-33. PubMed ID: 25867369
[TBL] [Abstract][Full Text] [Related]
19. Growth Differentiation Factor-15 as a Predictor of Idiopathic Membranous Nephropathy Progression: A Retrospective Study.
Ham YR; Song CH; Bae HJ; Jeong JY; Yeo MK; Choi DE; Na KR; Lee KW
Dis Markers; 2018; 2018():1463940. PubMed ID: 29682097
[TBL] [Abstract][Full Text] [Related]
20. Growth/differentiation factor 15 (GDF-15) as new potential serum marker in patients with metastatic colorectal cancer.
Vocka M; Langer D; Fryba V; Petrtyl J; Hanus T; Kalousova M; Zima T; Petruzelka L
Cancer Biomark; 2018; 21(4):869-874. PubMed ID: 29400662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
